Category: June 2021

Michael Sassano and Antonio Guedelha: GMP Series Part 4: Laboratory Set-Up

The laboratory is both one of the most active and one of the most critical rooms in a GMP facility. The laboratory generates all the quality control reporting necessary to prove the quality of your final products. Laboratories have diverse diagnostic equipment pertinent to your operation, and depending on your budget, these tools can increase self-sufficiency and accuracy. Organizing the lab right is another step in your Good Manufacturing Practice (GMP) approval process that will guide your product quality and innovations.

Read More

Rod Kight: Is Delta-8 THC “Synthetic”? Does It Matter?

There are hundreds, perhaps thousands, of companies involved in the Δ8THC segment of the hemp industry. Due to an oversupply in the market of hemp biomass, hemp extract, and CBD, we have seen a precipitous drop in both prices and profits for these commodities. In contrast, Δ8THC sales are exploding. For this reason, some contend that Δ8THC is singlehandedly saving the hemp industry from economic annihilation. Others, however, contend that Δ8THC is dangerous to the hemp industry’s reputation.

Read More

Hoban Law: Cannabinoids 101

Given the relatively nascent nature of cannabis regulation, new cannabinoid discoveries and trends are happening with greater speed. Issues surrounding naturally occurring and synthetically derived cannabinoids are mounting and lines being drawn. Ultimately, products with intoxicating cannabinoids will find themselves in the marijuana regulated space while consumers will regularly find hemp products on mainstream retail shelves.

Read More

Vincente Sederberg: Cannabis Trademarks 101

In an industry that runs on innovation and differentiation, a cannabis brand’s identity is among its most valuable—and most prone to copying—assets. It’s a common myth that cannabis industry brands cannot get trademark protection. In fact, many cannabis-related trademarks are registered with the U.S. Patent and Trademark Office (USPTO), including U.S. Weed Channel, MedMen, Cheech’s Private Stash, and GOT GUMMIES? to name a few.

Read More

Foley: The City of Denver a Trendsetter in Cannabis Reform?

On April 20, 2021, Denver Mayor, Michael Hancock, signed the Marijuana Omnibus Bill and Marijuana Hospitality Bill into law, which make significant changes to Denver’s current cannabis laws.  These changes directly address hot-button items such as social equity and permanently implement the relaxation of certain regulations initially implemented for safety purposes during the pandemic.  These changes are long overdue and signify that Denver may be assuming the mantle of trendsetter for a post COVID-19 cannabis industry.

Read More

Seyfarth Shaw: California District Court Dismisses Disability Claims Based on Failed Preemployment Marijuana Screen

Recently, when dismissing a job-applicant’s disability discrimination claims brought under California state law, the U.S. District Court for the Central District of California issued two welcome reminders to employers.  First, an employer can condition an offer of employment on the completion of a preemployment drug screen, including a test for marijuana. This is true even though California has legalized marijuana for both recreational and medical purposes.  Second, an employer is not under any obligation to engage in the interactive process before an applicant passes a pre-employment drug screen.

Read More

Perkins Coie: United States: FTC Continues Crackdown On Unsupported CBD Marketing

Today, the U.S. Federal Trade Commission (FTC) announced a settlement in its most recent law enforcement action in its ongoing efforts to monitor the marketplace regarding misleading cannabidiol (CBD) product claims. The action targets Kushly Industries LLC (Kushly) and the company’s sole officer for allegedly making false or unsupported health benefit claims about Kushly’s CBD product.

Read More
Loading

New

Cannabis Law Journal – Editorial Board Members

Editor – Sean Hocking

Author Bios

Canada
Matt Maurer – Minden Gross
Jeff Hergot – Wildboer Dellelce LLP

Costa Rica
Tim Morales – The Cannabis Industry Association Costa Rica

Nicaragua
Elvin Rodríguez Fabilena

USA

General
Julie Godard
Carl L Rowley -Thompson Coburn LLP

Arizona
Jerry Chesler – Chesler Consulting

California
Ian Stewart – Wilson Elser Moskowitz Edelman & Dicker LLP
Otis Felder – Wilson Elser Moskowitz Edelman & Dicker LLP
Lance Rogers – Greenspoon Marder – San Diego
Jessica McElfresh -McElfresh Law – San Diego
Tracy Gallegos – Partner – Fox Rothschild

Colorado
Adam Detsky – Knight Nicastro
Dave Rodman – Dave Rodman Law Group
Peter Fendel – CMR Real Estate Network
Nate Reed – CMR Real Estate Network

Florida
Matthew Ginder – Greenspoon Marder
David C. Kotler – Cohen Kotler

Illinois
William Bogot – Fox Rothschild

Massachusetts
Valerio Romano, Attorney – VGR Law Firm, PC

Nevada
Neal Gidvani – Snr Assoc: Greenspoon Marder
Phillip Silvestri – Snr Assoc: Greenspoon Marder

Tracy Gallegos – Associate Fox Rothschild

New Jersey

Matthew G. Miller – MG Miller Intellectual Property Law LLC
Daniel T. McKillop – Scarinci Hollenbeck, LLC

New York
Gregory J. Ryan, Esq. Tesser, Ryan & Rochman, LLP
Tim Nolen Tesser, Ryan & Rochman, LLP
Cadwalader, Wickersham & Taft LLP

Oregon
Paul Loney & Kristie Cromwell – Loney Law Group
William Stewart – Half Baked Labs

Pennsylvania
Andrew B. Sacks – Managing Partner Sacks Weston Diamond
William Roark – Principal Hamburg, Rubin, Mullin, Maxwell & Lupin
Joshua Horn – Partner Fox Rothschild

Washington DC
Teddy Eynon – Partner Fox Rothschild